CompoAtlas

Joint Formula

Natural health product licensed in Canada

Licence holder
Arbonne International, LLC
NPN or DIN-HM
80028662
Status
Inactive licence
Licence date
16 December 2011
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Acide ascorbique

20 mg60,000 µg

Non-medicinal ingredients

Stéarate de magnésium, Maltodextrine, Microcrystalline cellulose, cellulose, Acide stéarique, Croscarmellose de sodium, Poudre de racine de gingembre, Phosphate de calcium, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps in connective tissue formation. Antioxidant for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80028662

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line